Clinical trial

Anti-inflammatory Status in DM2 Treated Patients

NCT04392557

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2020-07-01

PhasePHASE4

Study timeline

Study start (actual)2020-07-01Date precision: day

Registry last updated2020-09-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 2unresolved

Interventions

Metformin / alogliptin Oral ProductDRUG

Metformin / Pioglitazone PillDRUG

triple therapyDRUG

Sponsors & collaborators

University of Catanzarolead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04392557 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.